Computer-Assisted Drug Formulation Design: Novel Approach in Drug Delivery

Molecular Pharmaceutics

Volumn 12, Issue 8, 2015, Pages 2800-2810

  Metwally, Abdelkader A ^a   Hathout, Rania M ^a,b  

^a Faculty of Computer Science   (Egypt)

^b Ain Shams University   (Egypt)

Author keywords

docking; formulation; informatics; molecular dynamics; nanoparticles; neural networks

Indexed keywords

ACECLOFENAC; ARTEMETHER; CLOZAPINE; CURCUMIN; CYCLOSPORIN A; CYTARABINE; DOCETAXEL; ETOPOSIDE; INDOMETACIN; KETOPROFEN; MEPIVACAINE; NANOPARTICLE; PACLITAXEL; PHENOBARBITAL; PIROXICAM; POLYGLACTIN; POLYMER; PRAZIQUANTEL; RALOXIFENE; SILIBININ; SOLID LIPID NANOPARTICLE; TAMOXIFEN CITRATE; TRIAMCINOLONE ACETONIDE; TRIPALMITIN; VALPROIC ACID; VANCOMYCIN; VINPOCETINE; ANTINEOPLASTIC AGENT; DRUG CARRIER; LACTIC ACID; LIPID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; ARTIFICIAL NEURAL NETWORK; CHEMICAL STRUCTURE; COMPUTER AIDED DESIGN; COMPUTER MODEL; DATA MINING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENERGY; INFORMATION SCIENCE; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NANOTECHNOLOGY; PREDICTION; PRIORITY JOURNAL; CHEMISTRY; HUMAN; MEDICINAL CHEMISTRY; PARTICLE SIZE; PROCEDURES;

ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; COMPUTER-AIDED DESIGN; CURCUMIN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HUMANS; LACTIC ACID; LIPIDS; MOLECULAR DYNAMICS SIMULATION; NANOPARTICLES; NEURAL NETWORKS (COMPUTER); PARTICLE SIZE; POLYGLYCOLIC ACID;

EID: 84938327562     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500740d     Document Type: Article

References (41)

1. Lopes, R.; Eleuterio, C. V.; Goncalves, L. M. D.; Cruz, M. E. M.; Almeida, A. J. Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis Eur. J. Pharm. Sci. 2012, 45 (4) 442-450 10.1016/j.ejps.2011.09.017
2. Mikhaylov, G.; Mikac, U.; Magaeva, A. A.; Itin, V. I.; Naiden, E. P.; Psakhye, I.; Babes, L.; Reinheckel, T.; Peters, C.; Zeiser, R.; Bogyo, M.; Turk, V.; Psakhye, S. G.; Turk, B.; Vasiljeva, O. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment Nat. Nanotechnol. 2011, 6 (9) 594-602 10.1038/nnano.2011.112
3. Dahlman, J. E.; Barnes, C.; Khan, O. F.; Thiriot, A.; Jhunjunwala, S.; Shaw, T. E.; Xing, Y.; Sager, H. B.; Sahay, G.; Speciner, L.; Bader, A.; Bogorad, R. L.; Yin, H.; Racie, T.; Dong, Y.; Jiang, S.; Seedorf, D.; Dave, A.; Singh Sandhu, K.; Webber, M. J.; Novobrantseva, T.; Ruda, V. M.; Lytton-Jean, A. K.; Levins, C. G.; Kalish, B.; Mudge, D. K.; Perez, M.; Abezgauz, L.; Dutta, P.; Smith, L.; Charisse, K.; Kieran, M. W.; Fitzgerald, K.; Nahrendorf, M.; Danino, D.; Tuder, R. M.; von Andrian, U. H.; Akinc, A.; Panigrahy, D.; Schroeder, A.; Koteliansky, V.; Langer, R.; Anderson, D. G. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight Nat. Nanotechnol. 2014, 9 (8) 648-655 10.1038/nnano.2014.84
4. Soltani, S.; Sardari, S.; Soror, S. A. Computer simulation of a novel pharmaceuticalsilicon nanocarrier Nanotechnol., Sci. Appl. 2010, 3, 149-157 10.2147/NSA.S8378
5. Alayoubi, A.; Satyanarayanajois, S. D.; Sylvester, P. W.; Nazzal, S. Molecular modelling and multisimplex optimization of tocotrienol-rich self emulsified drug delivery systems Int. J. Pharm. 2012, 426 (1-2) 153-161 10.1016/j.ijpharm.2012.01.049
6. Uccello-Barretta, G.; Balzano, F.; Sicoli, G.; Friglola, C.; Aldana, I.; Monge, A.; Paolino, D.; Guccione, S. Combining NMR and molecular modelling in a drug delivery context: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into beta-cyclodextrin Bioorg. Med. Chem. 2004, 12 (2) 447-458 10.1016/j.bmc.2003.10.033
7. Baskaran, C.; Ramachandran, M. Computational molecular docking studies on anticancer drugs Asian Pac. J. Trop. Dis. 2012, 2, S734-S738 10.1016/S2222-1808(12)60254-0
8. Leonardi, D.; Salomon, C. J.; Lamas, M. C.; Olivieri, A. C. Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks Int. J. Pharm. 2009, 367 (1-2) 140-147 10.1016/j.ijpharm.2008.09.036
9. Gasperlin, M.; Podlogar, F.; Sibanc, R. Evolutionary artificial neural networks as tools for predicting the internal structure of microemulsions J. Pharm. Pharm. Sci. 2008, 11 (1) 67-76
10. Sutariya, V.; Groshev, A.; Sadana, P.; Bhatia, D.; Pathak, Y. Artificial neural network in drug delivery and pharmaceutical research Open Bioinf. J. 2013, 7, 49-62 10.2174/1875036201307010049
11. Husseini, G. A.; Mjalli, F. S.; Pitt, W. G.; Abdel-Jabbar, N. Using artificial neural networks and model predictive control to optimize acoustically assisted Doxorubicin release from polymeric micelles Technol. Cancer Res. Treat. 2009, 8 (6) 479-488 10.1177/153303460900800609
12. Kishore, N.; Dhanalekshmi, U. M.; Raja, M. D.; Bhavani, S.; Reddy, P. N. Design and in vitro evaluation of solid-lipid nanoparticle drug delivery for aceclofenac J. Dispersion Sci. Technol. 2012, 33 (1-3) 96-102 10.1080/01932691.2010.534293
13. Raina, N.; Goyal, A. K.; Pillai, C. R.; Rath, G. Development and characterization of artemether loaded solid lipid nanoparticles Indian J. Pharm. Educ. Res. 2013, 47 (2) 123-128
14. Venkateswarlu, V.; Manjunath, K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles J. Controlled Release 2004, 95 (3) 627-638 10.1016/j.jconrel.2004.01.005
15. Reddy, L. H.; Sharma, R. K.; Chuttani, K.; Mishra, A. K.; Murthy, R. R. Etoposide-incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies AAPS J. 2004, 6 (3) 55 10.1208/aapsj060323
16. Mundhada, D. R.; Bhaskaran, S. Tripalmitin based mepivacaine solid lipid nanoparticles for topical application Int. J. Res. Pharm. Biomed. Sci. 2011, 2 (3) 1073-1076
17. Verma, V. K.; Ram, A. Preparation, characterization and in-vitro release of piroxicam-loaded solid lipid nanoparticles Int. J. Pharm. Sci. Res. 2010, 3 (3) 1136-1146
18. Mishra, A.; Vuddanda, P. R.; Singh, S. Intestinal lymphatic delivery of praziquantel by solid lipid nanoparticles: Formulation design, in vitro and in vivo studies J. Nanotechnol. 2014, 2014, 1-12 10.1155/2014/351693
19. Kumar, P. P.; Gayatri, P.; Satish, D.; Kumar, K. V.; Rao, Y. M. Development and evaluation of Raloxifene solid lipid nanoparticles: influence of triglyceride lipids on in vitro release kinetics Novel Sci. Int. J. Pharm. Sci. 2012, 1 (9-10) 698-707
20. Sadiq, A. A.; Abdul Rassol, A. A. Formulation and evaluation of Silibenin loaded solid lipid nanoparticles for peroral use targeting lower part of gastrointestinal tract Int. J. Pharm. Pharm. Sci. 2014, 6 (1) 55-67
21. Reddy, L. H.; Vivek, K.; Bakshi, N.; Murthy, R. S. R. Tamoxifen citrate loaded solid lipid nanoparticles SLN (TM)): Preparation, characterization, in vitro drug release, and pharmacokinetic evaluation Pharm. Dev. Technol. 2006, 11 (2) 167-177 10.1080/10837450600561265
22. Morsi, N. M.; Ghorab, D. M.; Badie, H. A. Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization Pharm. Dev. Technol. 2013, 18 (3) 736-744 10.3109/10837450.2012.734513
23. Keum, C. G. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid Int. J. Nanomed. 2011, 6, 2225 10.2147/IJN.S24547
24. Sun, Y.; Yu, B.; Wang, G.; Wu, Y.; Zhang, X.; Chen, Y.; Tang, S.; Yuan, Y.; Lee, R. J.; Teng, L.; Xu, S. Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxel Colloids Surf., B 2014, 123, 716-723 10.1016/j.colsurfb.2014.10.007
25. Sabzevari, A.; Adibkia, K.; Hashemi, H.; Hedayatfar, A.; Mohsenzadeh, N.; Atyabi, F.; Ghahremani, M. H.; Dinarvand, R. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies Eur. J. Pharm. Biopharm. 2013, 84 (1) 63-71 10.1016/j.ejpb.2012.12.010
26. Barichello, J. M.; Morishita, M.; Takayama, K.; Nagai, T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Dev. Ind. Pharm. 1999, 25 (4) 471-476 10.1081/DDC-100102197
27. Yadav, K. S.; Sawant, K. K. Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles AAPS PharmSciTech 2010, 11 (3) 1456-1465 10.1208/s12249-010-9519-4
28. Pronk, S.; Pall, S. É.; Schulz, R.; Larsson, P.; Bjelkmar, P.; Apostolov, R.; Shirts, M. R.; Smith, J. C.; Kasson, P. M.; van der Spoel, D.; Hess, B.; Lindahl, E. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit Bioinformatics 2013, 29 (7) 845-854 10.1093/bioinformatics/btt055
29. Vanommeslaeghe, K.; Hatcher, E.; Acharya, C.; Kundu, S.; Zhong, S.; Shim, J.; Darian, E.; Guvench, O.; Lopes, P.; Vorobyov, I.; Mackerell, A. D. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields J. Comput. Chem. 2010, 31 (4) 671-690 10.1002/jcc.21367
30. Trott, O.; Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J. Comput. Chem. 2010, 31 (2) 455-461 10.1002/jcc.21334
31. Hou, D.; Xie, C.; Huang, K.; Zhu, C. The production and characteristics of solid lipid nanoparticles (SLNs) Biomaterials 2003, 24 (10) 1781-1785 10.1016/S0142-9612(02)00578-1
32. Youshia, J.; Kamel, A. O.; El, S. A.; Mansour, S. Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide Int. J. Nanomed. 2012, 7, 2483-2496 10.2147/IJN.S28307
33. Abdel-Hafez, S. M.; Hathout, R. M.; Sammour, O. A. Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs Int. J. Biol. Macromol. 2014, 64, 334-340 10.1016/j.ijbiomac.2013.11.041
34. Jose, S.; Ansa, C. R.; Cinu, T. A.; Chacko, A. J.; Aleykutty, N. A.; Ferreira, S. V.; Souto, E. B. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting Int. J. Pharm. 2013, 441 (1-2) 516-526 10.1016/j.ijpharm.2012.10.049
35. Wang, R.; Lai, L.; Wang, S. Further development and validation of empirical scoring functions for structure-based binding affinity prediction J. Comput.-Aided Mol. Des. 2002, 16 (1) 11-26 10.1023/A:1016357811882
36. Nettles, J. H.; Jenkins, J. L.; Bender, A.; Deng, Z.; Davies, J. W.; Glick, M. Bridging chemical and biological space: "Target fishing" using 2D and 3D molecular descriptors J. Med. Chem. 2006, 49 (23) 6802-6810 10.1021/jm060902w
37. Huang, Y.; Yao, Q.; Zhu, C.; Zhang, X.; Qin, L.; Wang, Q.; Pan, X.; Wu, C. Comparison of novel granulated pellet-containing tablets and traditional pellet-containing tablets by artificial neural networks Pharm. Dev. Technol. 2014, 1 10.3109/10837450.2014.910809
38. Perai, A. H.; Nassiri, M. H.; Asadpour, S.; Bahrampour, J.; Mansoori, G. A comparison of artificial neural networks with other statistical approaches for the prediction of true metabolizable energy of meat and bone meal Poult. Sci. 2010, 89 (7) 1562-1568 10.3382/ps.2010-00639
39. Hu, L.; Tang, X.; Cui, F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs J. Pharm. Pharmacol. 2004, 56 (12) 1527-1535 10.1211/0022357044959
40. Tabatt, K.; Kneuer, C.; Sameti, M.; Olbrich, C.; Muller, R. H.; Lehr, C. M.; Bakowsky, U. Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes J. Controlled Release 2004, 97 (2) 321-332 10.1016/j.jconrel.2004.02.029
41. Ajeet, A. QSAR study of methionine aminopeptidase inhibitors as anti-cancer agents Using MLR Approach Am. J. Pharmacol. Sci. 2013, 1 (5) 80-83